Related Experiment Video
Updated: May 21, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription
Hilal S Khalil1, Hemanth Tummala, Tedd R Hupp
1School of Contemporary Sciences, University of Abertay, Kydd Building, 40 Bell street, Dundee DD1 1HG, UK.
Abstract:
Ataxia-telangiectasia mutated (ATM) kinase is a component of a signalling mechanism that determines the process of decision-making in response to DNA damage and involves the participation of multiple proteins. ATM is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex, and orchestrates signalling cascades that initiate the DNA damage response. Cells lacking ATM are hypersensitive to insults, particularly genotoxic stress, induced through radiation or radiomimetic drugs. Here, we investigate the degree of ATM activation during time-dependent treatment with genotoxic agents and the effects of ATM on phospho-induction and localization of its downstream substrates. Additionally, we have demonstrated a new cell-cycle-independent mechanism of ATM gene regulation following ATM kinase inhibition with KU5593. Inhibition of ATM activity causes induction of ATM protein followed by oscillation and this mechanism is governed at the transcriptional level. Furthermore, this autoregulatory induction of ATM is also accompanied by a transient upregulation of p53, pATR and E2F1 levels. Since ATM inhibition is believed to sensitize cancer cells to genotoxic agents, this novel insight into the mechanism of ATM regulation might be useful for designing more precise strategies for modulation of ATM activity in cancer therapy.
Insights
Ataxia-telangiectasia mutated (ATM) kinase regulates DNA damage response. Inhibiting ATM kinase triggers its own induction and upregulates key proteins, offering new cancer therapy strategies.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Ataxia-telangiectasia mutated (ATM) kinase is crucial for DNA double-strand break (DSB) repair and the DNA damage response.
- ATM activation by the MRN complex initiates signaling cascades, and ATM-deficient cells exhibit hypersensitivity to genotoxic stress.
Purpose of the Study:
- To investigate ATM activation kinetics and downstream substrate phosphorylation during genotoxic agent treatment.
- To elucidate a novel cell-cycle-independent mechanism of ATM gene regulation following ATM kinase inhibition.
Main Methods:
- Time-dependent treatment with genotoxic agents.
- Analysis of ATM activation, downstream substrate phosphorylation, and localization.
- Investigation of ATM gene regulation via transcriptional mechanisms after ATM kinase inhibition with KU5593.
Main Results:
- ATM kinase inhibition leads to a cell-cycle-independent induction of ATM protein, characterized by oscillation and transcriptional regulation.
- This autoregulatory induction of ATM is accompanied by transient upregulation of p53, pATR, and E2F1.
- ATM activation dynamics and downstream effects were characterized during genotoxic stress.
Conclusions:
- A novel autoregulatory mechanism of ATM gene expression exists, governed transcriptionally and independent of the cell cycle.
- Understanding this ATM regulation provides insights for developing targeted cancer therapies that modulate ATM activity.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
PI3K/mTOR/AKT Signaling Pathway
